Sponsor or institution
Clinical trials and research at ImmuneOncia Therapeutics Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by ImmuneOncia Therapeutics Inc. that are recruiting, in South Korea. By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
IMC-001 for metastatic or locally advanced solid tumors with high tumor mutational burden
This trial will test whether IMC-001 helps adults with metastatic or locally advanced solid tumors that have high tumor mutational burden (TMB-H).
-
Testing IMC-002 in patients with advanced cancer who have not responded to standard treatments
This study is testing a new treatment called IMC-002 in patients with advanced cancer who haven't had success with regular therapies to see if it can help them.
Quick answers
How many clinical trials run by ImmuneOncia Therapeutics Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.